The candidates for new types proposed by the laboratories of H. W. Wilkinson, J. Jelinkova, B. Perch, and S. Rabinowitz were antigenically compared and found to be distinct from the established types. On the other hand, identity between some of the candidates was found: three belonged to the new type IV and two shared the NTi antigen. Strains with NT1 antigen were given the working label "provisional type V." A distribution study identified 102 type IV strains and 53 provisional type V strains among isolates from 15 countries.
There is ample evidence that the antigenic differentiation of group B Streptococcus (GBS) (Streptococcus agalactiae) strains into serotypes (serovars) is useful in the epidemiological, pathogenetic, immunological, prophylactic-therapeutic, and taxonomic respects. However, Lancefield's (7, 8) classical scheme of polysaccharide types (Ta, Ib, Il, and III), even if supplemented with the protein antigens R, X (10, 11) , and Ibc (9, 17, 18) Type IV and provisional type V strains have reportedly also been identified in laboratories in Denmark (5, 12), Israel (13) , and the United States (6, 16) .
Strains nonclassifiable by this extended typing scheme are being tested or checked in our laboratory for possession of the antigens of the NT6 (16) or 7271 (12) However, the character of our sets of strains cannot supply generally valid information about the frequency of type IV and provisional type V strains in current material. The new antigens were detected retrospectively in nontypable strains from the previous 20-year period. They were also demonstrated in strains selected by laboratories abroad from large sets of isolates (Geslin, France; Koshi, India; Bochkov and Semina, USSR; Tay Leng, Singapore; Pavlatos, Greece) and in some Czechoslovak field strains isolated after 1982, by which time we already were routinely typing GBS with the extended set of sera, i.e., containing type IV and provisional type V. According to a merely approximative estimate, this system will reduce the number of nontypable strains (i.e., those lacking polysaccharide antigens) by half.
We have already forwarded the type IV immunizing strain, on request, to a number of investigators abroad who have decided to extend their GBS typing schemes. As far as we are informed, type IV antiserum is now used on a routine basis in some laboratories in the following countries: Den Unequivocal interpretation of comparative data presupposes not only that new types are named uniformly, but also that uniform reference serum-producing strains are used.
In our search for "type-determining" polysaccharides in nontypable strains, we have used with advantage the method of detecting sialic acid (which is a component of type antigen [14] ) by reaction with the sialic acid-specific lectin from the snail Cepaea hortensis (15) .
Besides the demonstration of polysaccharide antigens, also of practical significance is the detection of the c, R, and X protein antigens. These antigens (especially the c protein) represent in many nontypable strains the only, even if a partial, antigenic characteristic. In addition, their presence allows a more detailed differentiation of strains possessing one of the basic, type-specific polysaccharides. At present, another possibility is opening for differentiating GBS thanks to the finding that c protein exists in two antigenically distinct fractions (1, 6, 17) .
The geographical distribution data presented above meet another of the criteria of the International Committee on Systematic Bacteriology for the recognition of a new taxon. This point of view is also applied by the corresponding Subcommittee to the recognition of new serotypes of streptococcal species.
Biological and chemical characterization of type IV and provisional type V is under way.
